Cell MedX Corp.
CMXC · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $8,331 | $8,136 | $8,125 | $8,422 |
| - Cash | $6 | $15 | $7 | $34 |
| + Debt | $0 | $0 | $0 | $356 |
| Enterprise Value | $8,324 | $8,121 | $8,118 | $8,744 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$266 | $74 | $0 | -$131 |
| % Margin | – | – | – | – |
| Net Income | -$266 | -$219 | -$141 | -$140 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.01 | -0.014 | -0.007 | -0.007 |
| % Growth | 30.1% | -101.4% | -1.4% | – |
| Operating Cash Flow | -$108 | -$72 | -$30 | -$17 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$108 | -$72 | -$30 | -$17 |